Drug
Nbi 34060
Nbi 34060: highest development phase Phase 3, developed by Neurocrine Biosciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Neurocrine Biosciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| NBI-34060 NCT00525941 | Phase 3 | Insomnia |
Latest
No recent events.
Follow Nbi 34060 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.